X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Divis Laboratories with Strides Arcolab - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DIVIS LABORATORIES vs STRIDES SHASUN LTD - Comparison Results

DIVIS LABORATORIES    Change

Established in the year 1990, Divi's Laboratories has been focusing on CRAMS and is an established player in the custom chemical synthesis (CCS) and API/Intermediate segment. Around 50% of Divi's revenues are derived from custom manufacturing for glo... More

STRIDES SHASUN LTD 
   Change

Strides Arcolab is an Indian pharmaceutical company headquartered at Bangalore. The company is primarily involved in two businesses notably the pharma business and the specialized sterile products business branded as Agila. This segment focuses large... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DIVIS LABORATORIES STRIDES SHASUN LTD DIVIS LABORATORIES/
STRIDES SHASUN LTD
 
P/E (TTM) x 19.3 14.4 134.4% View Chart
P/BV x 4.2 1.9 215.0% View Chart
Dividend Yield % 1.5 0.5 276.4%  

Financials

 DIVIS LABORATORIES   STRIDES SHASUN LTD
EQUITY SHARE DATA
    DIVIS LABORATORIES
Mar-16
STRIDES SHASUN LTD
Mar-16
DIVIS LABORATORIES/
STRIDES SHASUN LTD
5-Yr Chart
Click to enlarge
High Rs2,4841,413 175.8%   
Low Rs918848 108.3%   
Sales per share (Unadj.) Rs142.3353.3 40.3%  
Earnings per share (Unadj.) Rs41.923.4 179.1%  
Cash flow per share (Unadj.) Rs46.341.0 113.0%  
Dividends per share (Unadj.) Rs10.005.00 200.0%  
Dividend yield (eoy) %0.60.4 132.9%  
Book value per share (Unadj.) Rs161.5320.4 50.4%  
Shares outstanding (eoy) m265.4789.35 297.1%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x12.03.2 373.7%   
Avg P/E ratio x40.648.3 84.0%  
P/CF ratio (eoy) x36.727.6 133.1%  
Price / Book Value ratio x10.53.5 298.6%  
Dividend payout %23.921.4 111.7%   
Avg Mkt Cap Rs m451,525100,988 447.1%   
No. of employees `0003.74.7 79.1%   
Total wages/salary Rs m3,6494,988 73.2%   
Avg. sales/employee Rs Th10,184.46,730.0 151.3%   
Avg. wages/employee Rs Th984.11,063.6 92.5%   
Avg. net profit/employee Rs Th2,998.5445.5 673.1%   
INCOME DATA
Net Sales Rs m37,76431,564 119.6%  
Other income Rs m8481,212 70.0%   
Total revenues Rs m38,61232,776 117.8%   
Gross profit Rs m14,1385,213 271.2%  
Depreciation Rs m1,1821,573 75.1%   
Interest Rs m231,803 1.3%   
Profit before tax Rs m13,7813,049 452.0%   
Minority Interest Rs m0127 0.0%   
Prior Period Items Rs m0-27 0.0%   
Extraordinary Inc (Exp) Rs m0-371 0.0%   
Tax Rs m2,662689 386.7%   
Profit after tax Rs m11,1192,089 532.1%  
Gross profit margin %37.416.5 226.7%  
Effective tax rate %19.322.6 85.6%   
Net profit margin %29.46.6 444.8%  
BALANCE SHEET DATA
Current assets Rs m30,94735,949 86.1%   
Current liabilities Rs m5,19519,402 26.8%   
Net working cap to sales %68.252.4 130.1%  
Current ratio x6.01.9 321.5%  
Inventory Days Days11771 164.6%  
Debtors Days Days85127 67.1%  
Net fixed assets Rs m17,02734,478 49.4%   
Share capital Rs m531894 59.4%   
"Free" reserves Rs m42,34122,601 187.3%   
Net worth Rs m42,87728,632 149.8%   
Long term debt Rs m527,455 0.0%   
Total assets Rs m49,68476,591 64.9%  
Interest coverage x595.02.7 22,110.2%   
Debt to equity ratio x01.0 0.0%  
Sales to assets ratio x0.80.4 184.4%   
Return on assets %22.45.1 441.2%  
Return on equity %25.97.3 355.3%  
Return on capital %32.28.2 394.1%  
Exports to sales %85.348.1 177.1%   
Imports to sales %22.914.5 158.5%   
Exports (fob) Rs m32,19815,192 211.9%   
Imports (cif) Rs m8,6544,565 189.6%   
Fx inflow Rs m32,27016,612 194.3%   
Fx outflow Rs m8,7755,292 165.8%   
Net fx Rs m23,49611,320 207.6%   
CASH FLOW
From Operations Rs m10,379717 1,448.4%  
From Investments Rs m-4,135-22,284 18.6%  
From Financial Activity Rs m-6,24129,488 -21.2%  
Net Cashflow Rs m38,073 0.0%  

Share Holding

Indian Promoters % 52.0 27.7 187.7%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 11.8 37.8 31.2%  
FIIs % 19.0 8.6 220.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.2 25.9 66.4%  
Shareholders   31,796 56,241 56.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DIVIS LABORATORIES With:   FRESENIUS KABI ONCO.  ELDER PHARMA  ALEMBIC LTD  ALKEM LABORATORIES  CADILA HEALTHCARE  

Compare DIVIS LABORATORIES With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Flat Finish to the Week; Cadila Healthcare Rallies 7%(Closing)

Indian share markets finished marginally higher for the week in a thin trade amid buying in pharma stocks, software stocks and capital good stocks.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

Dear PM Modi, India is Already Land of Self-Employed, and It Ain't Working(Vivek Kaul's Diary)

Aug 21, 2017

Most Indians who cannot find jobs, look at becoming self-employed.

It's the Best Time to Buy IT Stocks(Daily Profit Hunter)

Aug 16, 2017

The IT Sector could be in an uptrend till February 2019. Are you prepared to ride the trend?

Think Twice Before You Keep Money In A Savings Bank Account(Outside View)

Aug 22, 2017

Post demonetisation, a cut in bank savings deposits rates was in the offing.

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

DIVIS LABORATORIES SHARE PRICE


Aug 24, 2017 03:36 PM

TRACK DIVIS LABORATORIES

  • Track your investment in DIVIS LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DIVIS LABORATORIES

DIVIS LABORATORIES 5-YR ANALYSIS

COMPARE DIVIS LABORATORIES WITH

MARKET STATS